Details for Patent: 8,236,285
✉ Email this page to a colleague
Which drugs does patent 8,236,285 protect, and when does it expire?
Patent 8,236,285 protects ZOLPIMIST and is included in one NDA.
This patent has eighty-six patent family members in nine countries.
This patent has expired prematurely due to non-payment of maintenance fees. See details below.
Summary for Patent: 8,236,285
| Title: | Buccal, polar and non-polar spray containing zolpidem |
| Abstract: | Buccal aerosol sprays or capsules using polar and non-polar solvents have now been developed which provide zolpidem for rapid absorption through the oral mucosa, resulting in fast onset of effect. The buccal polar compositions of the invention comprise formulation I: aqueous polar solvent, zolpidem, and optional flavoring agent; formulation II: aqueous polar solvent, zolpidem, optionally flavoring agent, and propellant; formulation III: non-polar solvent, zolpidem, and optional flavoring agent; formulation IV: non-polar solvent, zolpidem, optional flavoring agent, and propellant; formulation V: a mixture of a polar solvent and a non-polar solvent, zolpidem, and optional flavoring agent; formulation VI: a mixture of a polar solvent and a non-polar solvent, zolpidem, optional flavoring agent, and propellant. |
| Inventor(s): | Dugger, III; Harry A. (Flemington, NJ), Abd El-Shafy; Mohammed (Hauppauge, NY) |
| Assignee: | Novadel Pharma Inc. (Flemington, NJ) |
| Application Number: | 12/576,457 |
|
Patent Claim Types: see list of patent claims | Use; Composition; |
Drugs Protected by US Patent 8,236,285
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aytu | ZOLPIMIST | zolpidem tartrate | SPRAY, METERED;ORAL | 022196-001 | Dec 19, 2008 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | Y | TREATMENT OF TRANSIENT INSOMNIA | ⤷ Sign Up | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,236,285
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2003262916 | ⤷ Sign Up | |||
| Australia | 2003262917 | ⤷ Sign Up | |||
| Australia | 2003270014 | ⤷ Sign Up | |||
| Australia | 2003270016 | ⤷ Sign Up | |||
| Australia | 2003270017 | ⤷ Sign Up | |||
| Australia | 2003270018 | ⤷ Sign Up | |||
| Australia | 2003272242 | ⤷ Sign Up | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
